Skip to content

Effects of Chinese medicine for supplementing qi and activating blood circulation, Tongguan Capsules on Restenosis after Coronary Stent Implantation

Effects of Chinese medicine for supplementing qi and activating blood circulation, Tongguan Capsules on Restenosis after Coronary Stent Implantation

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IIR-17011407
Enrollment
Unknown
Registered
2017-05-16
Start date
2017-07-01
Completion date
Unknown
Last updated
2017-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease

Interventions

Chinese medicine Group:Tongguan Capsules+standard conventional treatment

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) with the diagnosis of Coronary heart disease; (2) suffer from the Syndrome of qi deficiency and blood stasis based on Chinese Medicine theory; (3) To be aged between 3 to 80 years old; (4) signed the informed consent.

Exclusion criteria

Exclusion criteria: (1) the serious impairment of renal function(serum creatinine higher than 220umol/L for male, and 175umol/L for fomale); (2) the serious impairment of liver function (serum ALT higher than normal amount of the upper limit value of the three times); (3) Severe heart failure (cardiac function class IV or left ventricular ejection fraction less than 35%); (4) severe nervous system diseases (5) malignant tumors; (6) severe blood system; (7) Refuse to sign a consent form, or follow-up is poorer; (8) pregnant women, lactation and planning of women patients; (9) patients participate in other study.

Design outcomes

Primary

MeasureTime frame
Gensini Score;

Secondary

MeasureTime frame
Major adverse cardiovascular events;Quantization Table for TCM Syndrome Differentiation;

Countries

China

Contacts

Public ContactYuanshen Zhou

Guangdong Provincial Hospital of Chinese Medicine

13580347116@163.com+86 13580347116

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 27, 2026